James Hamilton

3PUBLICATIONS
40CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 23, 2024
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma.

James Brugarolas, Gregory Obara, Kathryn E Beckermann

|Oct 03, 2022
HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans.

Yuanqing Ma, Allison Joyce, Olivia Brandenburg

|Sep 29, 2017
RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg.

Christine I Wooddell, Man-Fung Yuen, Henry Lik-Yuen Chan

Pageof 1